Skip to main content
Published locations for MSS metastatic CRC: Patients without liver involvement may benefit from PD-1/PD-L1 inhibitors
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
MSS metastatic CRC: Patients without liver involvement may benefit from PD-1/PD-L1 inhibitors
User login
Username
Password
Reset your password
/content/mss-metastatic-crc-patients-without-liver-involvement-may-benefit-pd-1/pd-l1-inhibitors
/hematology-oncology/article/244822/gastrointestinal-cancer/mss-metastatic-crc-patients-without-liver